Vemurafenib and ipilimumab: New agents for metastatic melanoma

Megan Banaszynski, Jill M. Kolesar

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Vemurafenib and ipilimumab: New agents for metastatic melanoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science